PuSH - Publication Server of Helmholtz Zentrum München: The osteosarcomogenic effectiveness of the short lived <sup>224</sup>Ra compared with that of the long lived <sup>226</sup>Ra in mice.

Information

Clues to quality of journals

Open Access Policy of Helmholtz Association 2016

CC Licencences

Publication Metrics

Navigation

Home

Deutsch

EVA: Electronic Publishing

New EVA Application

Research

Advanced Search

Browse by ...

... HMGU-Authors/Consortia

... Organizational Structure

... Journal

... Publication Type

... Research Data

... Arbeitsgruppen

... Publication Year

Publication overview

Statistics

Statistics (last 5 years)

OA Publications

Publish

Submit Publication

Import publication from...

...EVA

Report missing publication

Highlights

Support & Contact

Contact persons

Help

Data protection

Helmholtz Open Science

JANE Journal Estimator

SHERPA/RoMEO

DOAJ

Export:

Text

Endnote (RIS) BIB

BibTeX

Müller, W.A. ; Luz, A.

The osteosarcomogenic effectiveness of the short lived ²²⁴Ra compared with that of the long lived ²²⁶Ra in mice.

Radiat. Res. 70, 444-448 (1977)

Publ. Version/Full Text

DOI

PMC

	Licenced for HMGU

Open Access Green as soon as Postprint is submitted to ZB.

Abstract
Metrics
Extra information

224Ra was applied with one single injection or with repeated injections (twice weekly over various time periods, up to 36 wk). In general the bone tumor incidence increased with dose but with the restriction that the maximum instantaneous dose rate be not too high. The 1080 rad total skeletal dose thus resulted in a bone tumor incidence between 15 and 90% depending on the length of the injection spans. These results were compared with the effect of singly injected long lived 226Ra, using data by M. Finkel et al. It was observed that the specific bone tumor production by 226Ra, expressed as incidence per unit of total accumulated skeletal dose, was steadily diminished with an increase of the dose. As a consequence, it was found that mice after a single injection of the long lived 226Ra within the tested dose range had in general a considerably lower bone tumor incidence than those mice having received comparable skeletal doses through repeated injections of the short lived 224Ra over a longer period.

Impact Factor

Scopus SNIP

Altmetric

0.000

PuSH - Publication Server of Helmholtz Zentrum München

The osteosarcomogenic effectiveness of the short lived 224Ra compared with that of the long lived 226Ra in mice.

The osteosarcomogenic effectiveness of the short lived ²²⁴Ra compared with that of the long lived ²²⁶Ra in mice.